Murphy, solicitor] Defendant(s): Commission of the European Communities Form of order sought - Quash the European Commission's Decision of 15 July 2005 relating to a proceeding under Article 82 of the EC Treaty and Article 54 of the EEA Agreement (Case COMP/A.37.507/F3 â€” AstraZeneca); - order the Commission to pay the applicants' costs of these legal proceedings.
They also consider that Article 82 EC, properly interpreted, did not impose on them an obligation to maintain a marketing authorisation for a product they no longer marketed, merely because it would make it easier for generics and parallel traders to compete with it.
